Revolutionizing Drug Development: Synthetic Nanodiscs

Join a 46-minute webinar led by Dr. Donghui Ma, Founder and CEO of DIMA Biotechnology LTD, exploring breakthrough developments in membrane protein research and drug development through Synthetic Nanodisc technology. Discover how this innovative approach addresses the challenges of working with transmembrane proteins, which are crucial targets for FDA-approved therapeutic drugs. Learn about the revolutionary polymer-based Nanodisc platform that enables the purification of membrane proteins to high homogeneity under aqueous conditions, offering advantages over traditional methods like detergent screening and virus-like particles. Explore how nanoscale disc-shaped structures can effectively house membrane proteins within lipid bilayers, creating a cleaner system for downstream assays compared to conventional membrane scaffold protein-based platforms. Gain insights into leveraging Synthetic Nanodiscs for antibody drug discovery and understand their practical applications in advancing membrane protein research and therapeutic development.